Related Experiment Video
Updated: Sep 2, 2025
07:40
A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
Published on: May 27, 2021
4.3K
Ezetimibe and Cancer: Is There a Connection?
Jia Gu1, Neng Zhu2, Hong-Fang Li1
1Laboratory of Stem Cell Regulation With Chinese Medicine and its Application, HunanUniversity of Chinese Medicine, Changsha, China.
Frontiers in Pharmacology
|August 4, 2022
Summary
Ezetimibe, a cholesterol absorption inhibitor, shows potential in cancer treatment and prevention. Studies indicate it does not increase cancer risk and may inhibit tumor growth through various mechanisms.
Area of Science:
- Oncology
- Pharmacology
- Cardiovascular Medicine
Background:
- High serum cholesterol and hypercholesterolemia are linked to cancer development.
- Ezetimibe effectively reduces cholesterol absorption by inhibiting NPC1L1.
- Preclinical data suggest ezetimibe possesses anti-cancer properties.
Purpose of the Study:
- To review the anti-cancer properties of ezetimibe.
- To elucidate the molecular mechanisms of ezetimibe's anti-cancer effects.
- To assess the safety of ezetimibe in combination with statins regarding cancer risk.
Main Methods:
- Review of preclinical models demonstrating ezetimibe's anti-cancer effects.
- Analysis of studies investigating ezetimibe's molecular mechanisms (anti-angiogenesis, stem cell suppression, immune modulation, etc.).
- Evaluation of clinical data on ezetimibe and statin combination therapy and cancer risk.
Main Results:
- Ezetimibe exhibits anti-cancer effects via multiple pathways, including anti-angiogenesis, stem cell suppression, anti-inflammation, immune enhancement, and anti-proliferation.
- Evidence suggests that ezetimibe, even when combined with statins, does not increase cancer risk.
- Accumulating data support ezetimibe's role in cancer inhibition.
Conclusions:
- Ezetimibe demonstrates significant potential as an anti-cancer therapeutic agent.
- Further research into ezetimibe for cancer treatment and prevention is warranted.
- Ezetimibe offers a promising option for managing hypercholesterolemia without elevating cancer risk.
Related Concept Videos
01:20Antiepileptic Drugs: Potassium Channel Activators
262
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
262
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
02:59Cancer Prevention
6.3K
Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Some...
6.3K
02:49Cancer Therapies
7.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K